Liraglutide Subcutaneous Injection 6 mg/mL solution Suppliers & Bulk Manufacturers
Available Forms: Subcutaneous injection/Pre filled Pen
Available Strengths: 6 mg/mL solution
Reference Brands: Victoza(US & EU)
Category: Diabetes
Liraglutide is a GLP-1 receptor agonist that mimics incretin hormones, stimulating insulin secretion, suppressing glucagon release, and delaying gastric emptying. Benefits include improved glycemic control in type 2 diabetes and weight loss (obesity management). It also reduces cardiovascular risk in high-risk patients. Administered once daily for convenience.
Product Description:
Liraglutide injection, approved by both the FDA and EMA, is prescribed for type 2 diabetes, weight management, and cardiovascular risk reduction. Marketed under brand names like Victoza® and Saxenda®, it requires a prescription and proper medical supervision. In the U.S., it carries a boxed warning for thyroid C-cell tumors, while the EU mandates PSURs and risk management plans. Cold-chain storage and pharmacovigilance are required in both regions. For regulatory-compliant sourcing and global distribution of liraglutide injection, visit PharmaTradz.com.
Liraglutide Subcutaneous Injection — third party manufacturing & bulk supply
Liraglutide Subcutaneous Injection 6 mg/mL solution is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Liraglutide Subcutaneous Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Liraglutide Subcutaneous Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Liraglutide is used to manage Type 2 diabetes mellitus and obesity. It helps control blood sugar levels, improves glycemic parameters, and supports weight reduction in patients with excess body weight. It is also prescribed to reduce cardiovascular risk factors in patients with diabetes.
Liraglutide is a synthetic analogue of human glucagon-like peptide-1 (GLP-1), produced using recombinant DNA technology. It acts as a GLP-1 receptor agonist to enhance glucose-dependent insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite.
The main trade names are Victoza (for Type 2 diabetes) and Saxenda (for obesity/weight management).
Liraglutide is manufactured by Novo Nordisk, a global leader in diabetes and obesity therapeutics.
The generic name is Liraglutide.
Brand names include Victoza and Saxenda.
Liraglutide is manufactured in Denmark by Novo Nordisk and distributed globally, including the USA, EU, Japan, India, and other regions.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
